Sunday, February 18, 2018
 
 
Company News: Page (1) of 1 - 04/16/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Joomee Shim, M.D., Joins The Oncology Institute of Hope and Innovation
 
(April 16, 2017)
Joomee Shim, M.D., Joins The Oncology Institute of Hope and Innovation

Dr. Joomee Shim is committed to provide excellence to her patients. Dr. Shim received both her BLA and medical degree within 6 years from the University of Missouri, Kansas City. She then completed her residency and fellowship at Stony Brook University Hospital in Stony Brook, NY.

During her fellowship, Dr. Shim was involved in the cardio oncology program that helped guide patients to closely monitor their cardiac status with their cardiologists while they were on cardio toxic medications.

Dr. Shim has worked to develop an effective work environment, placing patient safety as a priority as part of a patient safety initiative. Dr. Shim is skilled in performing bone marrow biopsies and placing intrathecal chemotherapy, as well as taking care of auto and allotransplant bone marrow patients.



Dr. Shim likes to travel to different places around the world to meet new people and understand varying cultures. Dr. Shim is fluent in Korean.

Professional Memberships:

  • ASCO (American Society of Clinical Oncology)
  • ASH (American Society of Hematology)
  • National Comprehensive Cancer Network

Patient Care Philosophy:

To deliver personalized comprehensive multidisciplinary patient care with compassion and empathy. Communication and education are key in empowering patients in understanding and treating their disease. Respect and supporting patients and their family through difficult times.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14247300.htm.


Page: 1


Related Keywords:
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • BC Platforms to Provide Real World Evidence Solutions to Pfizer in Cardiovascular Diseases
  • Knee Bursitis Market 2018 | with ~7.1% of CAGR | A Definite Shift towards the Developing World | Forecasts till 2023
  • Worldwide Wound Closure Device Market is Expected to grow 21 billion by the end of the forecasted period, 2016-2022
  • Intralytix Receives FDA Clearance to Initiate Phase I / IIa Clinical Trials
  • Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration

    Cancer
  • Digestive Center Launches ACTZYM, A Digestive Enzyme Designed to Optimize Overall Health and Wellness
  • PharmaMar Has Published the Results of Its Antibody Conjugate Active in Breast, Ovarian and Gastric Cancers that Express HER2
  • Merrimack to Present at the 2018 RBC Capital Markets Global Healthcare Conference
  • Rahr & Sons Brewing Company Has a Crush on Wipe Out Kids' Cancer
  • COA: Analysis Shows Ohio Hospitals Benefit From Recent Changes In Medicare Payment
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines